Involve primary-care doctor in retinal artery occlusion

Article

Referral to a primary-care physician is a critical component in the care of patients with a retinal artery occlusion because the ophthalmic event usually is a manifestation of a systemic disease, which by itself is associated with increased morbidity and mortality, according to experts.

Editor's Note: The February, March, and April issues of Optometry Times will explore why and how optometrists should look at patients globally in terms of their overall systemic health. Further emphasis will be placed on working collaboratively with colleagues in primary care and retina to ensure that all treatable conditions are addressed and to help patients maintain optimal vision.

In this three-part series, Advanstar Communications' Action for Outcomes initiative returns, this time with an in-depth look at vascular conditions. As well as serving as a wake-up call, the action plan emphasizes core competencies, best practices, and shared responsibility among all stakeholders in the patient's health-care ecosystem. An interdisciplinary approach to addressing this matter will provide specific knowledge and practical strategies to improve the treatment of patients with these conditions.

"The importance of determining and addressing the underlying cause of retinal arterial occlusive disease is underscored by available data that show post-event mortality rates of [about] 15% at 1 year and 55% after 7 years," said Dr. Gurwood, professor of clinical sciences, The Eye Institute of the Pennsylvania College of Optometry, Salus University, Philadelphia.

"Heyreh dispels the myth that an embolus does not have to be completely lodged in the vessel for occlusion to occur," he said. "It has to be stuck like a cork in a wine bottle. If the occlusion is not complete and blood can flow around the obstruction, patients will remain unaware of their precarious position."

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.